News

AutoGuide on MSN1d
This Was Acura's Most Popular Sedan—Now It's Being Discontinued
The Acura TLX is officially dead.After three decades on the road and over 1 million cars sold, Acura will end production of ...
autoevolution2d
Official: Another Sedan Killed Off in the U.S.
A direct successor is not on the horizon either, as after not being that popular anymore, this model is being replaced by an ...
Major car brand discontinues longstanding luxury model after 30 years
A MAJOR car brand is discontinuing a longstanding luxury model after several decades in production. The popular saloon model ...
Hosted on MSN2d
Dead: Acura TLX
The mid-size luxury sedan has been a staple in the Acura lineup since the mid-1990s, when the first TL debuted. In 2015, we ...
Acura Just Pulled The Plug On A Sedan It Once Called A Cornerstone
As a refresher, the 2025 TLX starts at $45,400 and features a turbocharged 2.0-liter four-cylinder engine with 272 hp (203 kW / 276 PS). Customers can also get the $58,050 TLX Type S, which sports a ...
MotorTrend on MSN3d
2025 Acura Cars Changes and Updates: Integra, TLX Prices Creep Up
For 2025, every Integra trim level receives a $600 bump in price except the Type S, which increases by $800. Otherwise, the Acura car is unchanged, though we expect the automaker will reveal news ...
Telix Pharmaceuticals (ASX:TLX) Confirms 2025 Revenue Forecast Between A$770 Million To A$800 Million
Telix Pharmaceuticals (ASX:TLX) recently confirmed its earnings guidance for FY 2025, with anticipated revenue between $770 and $800 million and an increase in R&D investment. This announcement came ...
Telix Pharmaceuticals stock drops as SEC probes disclosures tied to cancer treatment
Telix Pharmaceuticals' (NASDAQ:TLX) shares fell as much as 16% on Wednesday, after the Australian developer of radioactive drugs said it received a subpoena from the U.S. SEC seeking information about ...